Singapore markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
30.50+1.49 (+5.14%)
At close: 04:00PM EST
30.95 +0.45 (+1.48%)
Pre-market: 07:51AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.91B
Enterprise value 1.49B
Trailing P/E 21.09
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.83
Enterprise value/revenue 64.18
Enterprise value/EBITDA -4.64

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 327.14%
S&P500 52-week change 316.55%
52-week high 334.16
52-week low 318.00
50-day moving average 323.56
200-day moving average 326.31

Share statistics

Avg vol (3-month) 3984.65k
Avg vol (10-day) 32.78M
Shares outstanding 562.58M
Implied shares outstanding 662.58M
Float 846.39M
% held by insiders 16.61%
% held by institutions 1110.34%
Shares short (14 Nov 2023) 49.87M
Short ratio (14 Nov 2023) 414.23
Short % of float (14 Nov 2023) 419.19%
Short % of shares outstanding (14 Nov 2023) 415.78%
Shares short (prior month 12 Oct 2023) 410.39M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-35.13%
Return on equity (ttm)-60.55%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -321.62M
Net income avi to common (ttm)-304.96M
Diluted EPS (ttm)-4.87
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)422.42M
Total cash per share (mrq)6.76
Total debt (mrq)7.33M
Total debt/equity (mrq)1.86%
Current ratio (mrq)8.60
Book value per share (mrq)6.32

Cash flow statement

Operating cash flow (ttm)-214.29M
Levered free cash flow (ttm)-127.8M